We've All Lost Someone to This Disease. Here's What Science Actually Knows About Stopping It.

By now, we've all lost someone to this disease.

Maybe it was a grandparent who stopped recognizing faces. Maybe it was a parent who asked you the same question four times in ten minutes and didn't know they'd asked it before. Maybe it was a friend's spouse, retired at 62, diagnosed at 64, gone at 71. Maybe you haven't lost someone yet, but you've watched the early signs in someone you love, and you're sitting with the kind of dread that doesn't have a word for it.

I'll tell you firsthand: there is nothing more dreadful than watching someone's mental health deteriorate while they are otherwise physically healthy. The body works fine. The legs walk. The heart beats. The hands grip. But the person behind the eyes is leaving, slowly, in pieces, and there is nothing you can do but be there while it happens. It makes you feel helpless. It makes you feel angry at biology itself. And it shows us, with devastating clarity, how little we actually understand about our own brains.

7.2 million Americans over 65 are living with Alzheimer's disease right now. Globally, over 50 million people have some form of dementia. By 2050, that number is projected to reach 152 million. One in five women and one in ten men will develop Alzheimer's in their lifetime.

But here's the number that should change how you think about this disease: 40% of Alzheimer's cases are potentially preventable through modifiable risk factors. That's not genetics. That's not fate. That's lifestyle, diet, exercise, sleep, and habits that you control right now.

This article exists because the research has moved faster than the headlines. A drug combination was just identified that could delay Alzheimer's onset by seven years. A bacterium from your gums has been found in Alzheimer's brains. Exercise in midlife cuts risk by 45%. And the supplement stack you might already be taking for gut health and inflammation? Some of those compounds are showing up in brain protection studies.

Let's go through what we know, what we don't know, and what you can do right now.

The Breakthrough: Your Brain Has a Sewer System

Your brain produces waste. Every thought, every signal, every metabolic process generates byproducts. The two most infamous are amyloid-beta and tau proteins, which accumulate into the plaques and tangles that define Alzheimer's disease.

For decades, scientists focused on stopping the production of these proteins. What they overlooked was the other side of the equation: clearing them out.

Your brain has its own waste-disposal system called the glymphatic system. It works like a sewage network: cerebrospinal fluid flows through channels around blood vessels, flushing metabolic waste out of the brain and into the bloodstream for disposal. This system is most active during deep sleep, which is one reason poor sleep is linked to cognitive decline.

A company called Applied Cognition, led by researcher Paul Dagum, just published results from a clinical trial of a drug combination called ACX-02. It pairs dexmedetomidine (a sedative that enhances the slow brain waves that drive glymphatic clearance) with midodrine (which prevents the dangerous blood pressure drop that dexmedetomidine causes).

The result: ACX-02 was significantly more effective at clearing amyloid and tau proteins from the brain than placebo. The company estimates this clearance rate could defer Alzheimer's onset by approximately 7 years in people at risk.

Seven years. That's not a cure. But for a disease where the average time from diagnosis to death is 4 to 8 years, delaying onset by 7 years could mean the difference between developing symptoms at 72 or at 79. For many people, that's the difference between losing your mind and keeping it.

What You Can Control Right Now

The ACX-02 trial is promising but early. It had 19 participants. It needs larger trials, FDA review, and years of validation. You can't take it today.

But you can do things today that the evidence says matter. And some of them will surprise you.

Brush Your Teeth (Seriously)

This is the one that sounds absurd until you read the research.

Porphyromonas gingivalis is the bacterium primarily responsible for chronic gum disease (periodontitis). It produces enzymes called gingipains that can cross the blood-brain barrier. In 2019, researchers published a landmark study in Science Advances showing that P. gingivalis DNA and gingipains were found in the postmortem brain tissue of Alzheimer's patients.

In mouse models, chronic oral P. gingivalis infection led to neuroinflammation, amyloid-beta accumulation, and tau hyperphosphorylation, the three hallmarks of Alzheimer's pathology. A clinical trial of a gingipain inhibitor (COR 388) didn't produce significant cognitive benefits in humans, but the association between periodontal disease and Alzheimer's risk has been confirmed across multiple systematic reviews.

The practical takeaway is almost comically simple: brush your teeth twice a day, floss daily, and get regular dental cleanings. If periodontal bacteria can cross the blood-brain barrier and trigger the pathology of Alzheimer's, then basic oral hygiene is brain protection. It costs nothing. It takes four minutes a day. And the downside of being wrong is clean teeth.

Move Your Body

A 2025 study published in JAMA Network Open examined physical activity across early adulthood, midlife, and late life. The findings:

Midlife exercise reduced dementia risk by 41 to 45% in the highest activity group. Late-life activity showed 25 to 45% lower risk regardless of intensity. Even 3,800 steps per day (not 10,000, just 3,800) was associated with 25% lower dementia risk.

Exercise lowers insulin resistance, reduces chronic inflammation, improves cerebrovascular health, and may directly enhance glymphatic clearance. It's the single most evidence-supported intervention for Alzheimer's prevention, and it's free.

Feed Your Brain

The MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay) is the dietary pattern with the strongest evidence for brain protection. A 2025 systematic review found that 14 of 19 studies showed positive effects on cognitive function, and 10 of 11 studies showed reduced dementia or Alzheimer's risk.

What's in the MIND diet: leafy greens (at least 6 servings per week), berries (at least 2 servings per week), whole grains, fish, nuts, olive oil, and limited red meat, butter, cheese, pastries, and fried food.

Olive oil specifically: a study following over 90,000 participants found that consuming more than 7 grams of olive oil per day was associated with 28% lower risk of dementia-related death. The Mediterranean diet overall showed 33% lower cognitive impairment risk in the highest adherence group.

Omega-3 fatty acids (particularly DHA): dietary intake is associated with approximately 20% lower all-cause dementia risk. The evidence is stronger for eating fish than for taking fish oil supplements, but supplementation still shows benefits for attention and may slow decline.

Sleep Like Your Brain Depends on It

The glymphatic system, the same waste-clearance network that ACX-02 targets, is most active during deep sleep. A single night of sleep deprivation has been shown to produce a significant increase in amyloid-beta burden in the hippocampus and thalamus.

Sleep is when your brain takes out the trash. Every night you short-change your sleep, the trash accumulates. Over years and decades, that accumulation may be the difference between a sharp mind at 80 and a diagnosis at 70.

The Cholesterol Question and What We Don't Know

If you've read the cholesterol article, you know the relationship between cholesterol and health is more nuanced than "high = bad." The same complexity applies to Alzheimer's.

A 2025 meta-analysis of 55 observational studies covering over 7 million patients found that statin use was associated with an 18% reduction in Alzheimer's risk (HR 0.82). Sounds clear. But randomized controlled trials (the gold standard) show no significant reduction in dementia from statin therapy (OR 0.96).

The discrepancy is likely methodological: people who take statins tend to be more health-conscious overall, which confounds the observational data. The important takeaway: statins don't appear to CAUSE cognitive decline, despite the persistent myth. Studies have not demonstrated increased risk of Alzheimer's or cognitive impairment from lowering LDL cholesterol.

The Amyloid Hypothesis: 40 Years of Mostly Failure

Here's what we genuinely don't understand about Alzheimer's, and it's humbling.

The amyloid hypothesis has dominated Alzheimer's research for four decades. It says that amyloid-beta protein accumulation is the primary driver of the disease. Build-up of amyloid plaques triggers tau tangles, neuroinflammation, neuronal death, and cognitive decline.

Based on this hypothesis, pharmaceutical companies developed 52 anti-amyloid drugs. Of those, 31 have failed in clinical trials. None produced the kind of clear, consistent cognitive benefit that would validate the hypothesis conclusively.

The emerging view is that Alzheimer's is not a single disease but a syndrome with multiple contributing pathologies. Most Alzheimer's brains show not just amyloid plaques but also tau tangles, vascular damage, inflammation, and other protein accumulations. Pure amyloid-only Alzheimer's is extremely rare.

This doesn't mean the research was wasted. Each failure taught us something. The ACX-02 approach (clearing waste proteins via the glymphatic system) is a direct result of recognizing that maybe the problem isn't production of amyloid but the brain's inability to clear it. That's a fundamentally different approach, and it's showing promise precisely because the old approach didn't work.

"In 2024, the amyloid-cascade-hypothesis still remains a working hypothesis, no less but certainly no more." That assessment, from Frontiers in Aging Neuroscience, captures the state of the field with uncomfortable precision.

What I Actually Take (And Why It Maps to This Research)

If you've followed the health series on this site, you know the philosophy: food first, supplements to fill gaps, and only recommend what has evidence behind it. Here's how the Alzheimer's prevention research maps to actionable supplementation.

Full-Mega: The omega-3 fish oil I take daily. DHA is the omega-3 most strongly associated with brain health. Dietary omega-3 intake shows approximately 20% lower all-cause dementia risk. The anti-inflammatory effects are systemic, and neuroinflammation is a core component of Alzheimer's pathology. Triglyceride form for proper absorption, third-party tested for purity.

Core-21: Sleep support. The glymphatic system clears amyloid-beta during deep sleep. Core-21 combines magnesium, ashwagandha, and calming compounds that support restorative sleep without dependency. If the ACX-02 research proves anything, it's that getting waste proteins out of the brain matters enormously. Sleep is your body's built-in version of that process.

Liposomal Vitamin D3: Emerging evidence suggests vitamin D may improve cognitive function in people with dementia. Deficiency is widespread and linked to multiple neurodegenerative pathways. I take 5,000 IU daily with breakfast.

Opti-Greens 50: The polyphenols, antioxidants, and phytonutrients in a quality greens blend mirror many of the compounds in the MIND diet that show brain-protective effects. One scoop morning on an empty stomach.

M-Factor Men (or M-Factor Goddess for women): B12 and folate are the two B vitamins with the strongest evidence for cognitive support. A 2024 meta-analysis showed B12 + folate improved cognitive scores after 6 months, particularly when both are at adequate levels. A comprehensive multivitamin covers this without needing separate supplements.

What You Can Do This Week

We don't have a cure. We don't have a complete understanding of the disease. We have a glymphatic system drug that needs years of validation, a gum disease connection that's provocative but not yet therapeutic, and a dietary pattern that reduces risk but doesn't eliminate it.

What we have is enough to act on. And acting on incomplete evidence is better than waiting for perfect evidence while the disease progresses in someone you love.

The person I watched deteriorate didn't have the information in this article. Neither did I, at the time. I couldn't have changed the outcome. But I can make sure the people reading this know what the science says today, so they can make choices that their future selves, the ones who still remember their grandchildren's names, will be grateful for.